Key facts about Baraclude
What is Baraclude?
Baraclude is the brand name for entecavir and is available as an oral tablet and solution.
What dosages is Baraclude available in?
Baraclude is available as a 0.5 mg and 1 mg oral tablet and a
0.05 mg/mL oral solution.
What is Baraclude used for?
Baraclude is a first-choice antiviral medication used for the treatment of hepatitis B in adults and children at least 2 years of age.
How does Baraclude work?
Baraclude is a type of antiviral medication called a nucleoside reverse transcriptase inhibitor (NRTI). It inserts itself into the hepatitis B virus’s DNA. This prevents the virus from making copies of itself.
How do I take Baraclude?
Baraclude is typically taken once a day on an empty stomach. The dose depends on your liver health and your hepatitis B infection. For children under 16 years of age dose is based on the child’s weight.
Is it safe for me to take Baraclude?
Baraclude is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
Baraclude Common Side Effects
Common side effects of Baraclude include:
- Headache
- Fatigue
- Dizziness
- Nausea
- Higher liver lab results
Baraclude Serious Side Effects
Serious side effects are rare with Baraclude. Contact your healthcare provider immediately if you experience any of the following.
- Lactic acidosis: extreme tiredness, sudden weakness, fast and shallow breathing, loss of appetite, nausea, vomiting
- Liver problems: stomach pain, tiredness
Effects of other drugs, drug classes and over-the-counter products on Baraclude
The following medications may interact with Baraclude:
- Drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either Baraclude or the coadministered drug
Who makes Baraclude?
Bristol-Myers Squibb
Is Baraclude safe in pregnancy?
It is not known if Baraclude will harm your unborn baby. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Baraclude during pregnancy. Healthcare providers are encouraged to register patients by calling the Antiretroviral Pregnancy Registry (APR) at 1-800-258-4263.
